Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

You may be eligible if

• Man or nonlactating and nonpregnant woman, aged 18 to 70 years, inclusive, at the screening visit.
• Diagnosis of systemic lupus erythematosus more than 6 months before study day 1.
• History of positive antinuclear antibody titer of \>1:160 or equivalent.
• Biopsy-proven class V lupus nephritis within the last 2 years.
• Have been on a stable dose of oral corticosteroids (\<20 mg/day prednisone or equivalent) for 2 months before study day 1.